| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |